The effects of hair regrowth with intravenous immunoglobulin (IVIG) therapy. Two case reports
Author(s) -
Joseph A. Cahill,
Mark I. Hewatt
Publication year - 2017
Publication title -
journal of dermatology and dermatologic surgery
Language(s) - English
Resource type - Journals
eISSN - 2352-2429
pISSN - 2352-2410
DOI - 10.1016/j.jdds.2017.03.003
Subject(s) - medicine , antibody , demographics , intravenous immunoglobulin therapy , dermatology , immune system , intravenous immunoglobulins , hair loss , hair growth , immunoglobulin g , immunology , physiology , sociology , demography
Intravenous immunoglobulin (IVIG) is an immune modulating treatment used in a variety of immune mediated diseases. We report, two patients of different demographics, treated with IVIG for different neurological diagnoses who reported significant hair growth after starting IVIG treatments. To date, there have been no reports of using IVIG as a treatment for hair loss due to androgenic alopecia (AGA)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom